Evidence of active cytomegalovirus infection and increased production of IL-6 in tisseu specimens obtained from patients with inflammatory bowel diseases

Inflammatory Bowel Diseases

Volumn 9, Issue 3, 2003, Pages 154-161

  Rahbar, Afsar ^a   Boström, Lennart ^b   Lagerstedt, Ulla ^c   Magnusson, Inger ^b   Södergerg Naucler, Cecilia ^a   Sundqvist, Vivi Anne ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b STOCKHOLM SÖDER HOSPITAL   (Sweden)

^c ST GÖRAN S HOSPITAL   (Sweden)

Author keywords

Cytomegalovirus; Inflammatory bowel disease; Interleukin 6

Indexed keywords

AZATHIOPRINE; BETAMETHASONE; CYTOKINE; EARLY ANTIGEN; INTERLEUKIN 6; VIRUS ANTIGEN; VIRUS DNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ANTIGEN SPECIFICITY; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; COLONOSCOPY; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; ENTERITIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMAN TISSUE; IN SITU HYBRIDIZATION; INTESTINE CANCER; INTESTINE CELL; INTESTINE RADIOGRAPHY; INTESTINE SURGERY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TISSUE SECTION; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; ANTIGENS, VIRAL; CYTOMEGALOVIRUS; DNA, VIRAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-6; MALE; MIDDLE AGED;

EID: 0038054600     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-200305000-00002     Document Type: Article

References (42)

1. Freeman HJ, Shintka TK, Piercey JRA, et al. Cytomegalovirus infection of the gastrointestinal tract in a patient with late-onset immunodeficiency syndrome. Gastroenterology 1977;73:1397-1403.
2. Tedesco FJ, Moore S. Infectious diseases mimicking inflammatory bowel disease. Am Surg 1982;4:243-249.
3. Meiselman MS, Cello JP, Margaretten W. Cytomegalovirus colitis. Report of the clinical, endoscopic and pathologic findings in two patients with acquired immune deficiency. Gastroenterology 1985; 88:171-175.
4. Henson D. Cytomegalovirus inclusion bodies in the gastrointestinal tract. Arch Pathol 1972;93:477-482.
5. Parkes M, Satsangi J, Jewell D. Mapping susceptibility loci in inflammatory bowel disease: Why and how? Mol Med Today 1997; 3:546-553.
6. Radford-Smith G, Jewell D. Cytokines in inflammatory bowel disease. In: Allan RN, Rhodes JM, Hanauer SB, Keighley MRB, Williams JA, Fazio VW, eds. Inflammatory Bowel Disease. 3rd ed. New York: Churchill Livingstone; 1997:95-100.
7. Reinecker HC, Steffen M, Witthoeft T, et al. Enhanced secretion of tumor necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 1993;94:174-181.
8. Daig R, Andus T, Aschenbrenner E, et al. Increased interleukin-8 expression in the colon mucosa of patients with inflammatory bowel disease. Gut 1996;38:216-222.
9. Woywodt A, Neustock P, Kruse A, et al. Cytokine expression in intestinal mucosal biopsies. In situ hybridization of RNA for interleukin-1, interleukin-6 and tumor necrosis factor- in inflammatory bowel disease. Eur Cytokine Netw 1994;5:387-395.
10. St. Jeor S, Admirand J, Bruening E, et al. Induction of cytokines by human cytomegalovirus. In: Michelson S, Ploktin SA, eds. Multidisciplinary Approach to Understanding Cytomegalovirus Disease. New York: Excerpta Medica; 1993:123-126.
11. Lagneaux L, Delforge A, Snoeck R, et al. Perturbation of cytokine production by bone marrow stromal cells after cytomegalovirus infection. In: Michelson S, Ploktin SA, eds: Multidisciplinary Approach to Understanding Cytomegalovirus Disease. New York: Excerpta Medica; 1993:111-116.
12. Geist LJ, Dai LY. Cytomegalovirus modulates interleukin-6 gene expression. Transplantation 1996;62:653-658.
13. Brytting M, Sundqvist V-A, Stålhandske P, et al. Cytomegalovirus DNA detection of an immediate early protein gene with nested primer oligonucleotides. J Virol Methods 1992;32:127-138.
14. Wakefield AJ, Fox JD, Swayer AM, et al. Detection of herpes virus DNA in the large intestine of patients with ulcerative colitis and Crohn's disease using the nested polymerase chain reaction. J Med Virol 1992:38:183-90.
15. Cottone M, Pietrosi G, Martorana G, et al. Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis. Am J Gastroenterol 2001;96:773-5.
16. Streblow DN, Soderberg-Naucler C, Vieira J, et al. The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell 1999;99:511-520.
17. Soderberg-Naucler C, Fish KN, Nelson JA. Interferon-gamma and tumor necrosis factor-alpha specifically induce formation of cytomegalovirus-permissive monocyte-derived macrophages that are refractory to the antiviral activity of these cytokines. J Clin Invest 1997;100:3154-3163.
18. Jarvis MA, Fish KN, Soderberg-Naucler C, et al. Retrieval of human cytomegalovirus glycoprotein B from cell surface is not required for virus envelopment in astrocytoma cells. J Virol 2002; 76:5147-5155.
19. Bisping G, Lugering N, Lutke-Brintrup S, et al. Patients with inflammatory bowel disease (IBD) reveal increased induction capacity of intracellular interferon-gamma (IFN-gamma) in peripheral CD8+ lymphocytes co-cultured with intestinal epithelial cells. Clin Exp Immunol 2001;123:15-22.
20. Soderberg-Naucler C, Nelson JA. Immunomodulation of cytomegalovirus. In: Cunningham M, Fujinami R. Effects of Microbes on the Immune System. Philadelphia: Lippincott Williams & Wilkins 2000:399-418.
21. Ritter T, Brandt C, Prosch S, et al. Stimulation and inhibitory action of cytokines on the regulation of hCMV-IE promotor activity in human endothelial cells. Cytokines 2000;12:1163-1170.
22. Prösch S, Döcke WD, Reinke P, et al. Human cytomegalovirus reactivation in bone-marrow derived granulocyte/monocyte progenitor cells and mature monocytes. Intervirology 1999;42:308-313.
23. Klebanoff SJ, Vada MA, Harlan JM, et al. Stimulation of neutrophils by tumor necrosis factor. J Immunol 1986;136:4220-4225.
24. Coll PP, Pacala JT, Hamilton CW. Cytomegalovirus colitis in an older woman, successfully treated with Ganciclovir. J Fam Pract 1992;34:772-775.
25. Blair SD, Parkins RA, Forbes A. CMV colitis in an immunocompetent adult. J R Soc Med 1992:85:238-239.
26. Begos DG, Rappaport R, Jain D. Cytomegalovirus infection masquerading as an ulcerative colitis flare-up: case report and review of the literature. Yale J Bio Med 1996;69:323-328.
27. Hogerzand RA, Verpaget HW. Selective immunomodulation in patients with inflammatory bowel disease-future therapy or reality? Neth J Med 1996;48:64-67.
28. Vega R, Bertan X, Menacho M, et al. Cytomegalovirus infection in patients with inflammatory bowel disease. Am J Gastroenterol 1999;94:1053-1056.
29. Munoz-Juarez M, Pemberton JH, Sandborn WJ, et al. Misdiagnosis of specific cytomegalovirus infection of the ileoanal pouch as refractory idiopathic chronic pouchitis: report of two cases. Dis Colon Rectum 1999;42:117-120.
30. Brytting M, Sundqvist V. Stålhandske P, et al. Cytomegalovirus DNA detection of an immediate early protein gene with nested primer oligonucleotides. J Virol Methods 1991;32:127-138.
31. Larsson S, Söderberg-Naucler C, Wang F.Z, et al. Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and a majority of seroonegative healthy donors over time. Transfusion 1998;38:1-11.
32. Koutroubakis I, Pena AS. Genetics of inflammatory bowel disease. In: Allan RN, Rhodes JM, Hanauer SB, Keighley MRB, Williams JA, Fazio VW, eds. Inflammatory Bowel Disease. 3rd ed. New York: Churchill Livingstone; 1997:13-26.
33. Reinisch W, Gasche C, Tillinger W, et al. Clinical relevance of serum interleukin-6 in Crohn's disease: single point measurements, therapy monitoring, and prediction of clinical relapse. Am J Gastroenterol 1999;84:3739-3744.
34. Lagneaux L, Delforge A, Snoeck R, et al. Human cytomegalovirus increases constitutive production of interleukin-6 and leukemia inhibitory factor by bone marrow stromal cells. Blood 1996;87: 59-66.
35. Iwamoto GK, Konicek SA. Cytomegalovirus immediate early genes upregulate interleukin-6 gene expression. J Investig Med 1997;45:175-182.
36. Visseren FL, Verkerk MS, Bouter KP, et al. Interleukin-6 production by endothelial cells after infection with influenza virus and cytomegalovirus. J Lab Clin Med 1999;134:623-630.
37. Tong CY, Barkran A, Williams H, et al. Association of tumor necrosis factor alpha and interleukin 6 levels with cytomegalovirus DNA detection and disease after renal transplantation. J Med Virol 2001;64:29-34.
38. Devito-Haynes LD, Jankowska-Gan E, Heisey DM, et al. Soluble HLA class I in epithelial lining fluid of lung transplants: associations with graft outcome. Hum Immunol 1997;52:95-108.
39. Bodaghi B, Jones TR, Zipeto D, et al. Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: withdrawal of chemokines from the environment of cytomegalovirus-infected cells. J Exp Med 1998;188:855-866.
40. Margullies BJ, Browne H, Gibson W. Identification of the human cytomegalovirus G protein coupled receptor homologue encoded by UL33 in infected cells and enveloped virus particles. Virology 1996;225:111-125.
41. Hoffman M, Weinberg JB. Tumor necrosis factor alpha induces increased hydrogen peroxide production and Fc receptor expression, but not increased Ia antigen expression by peritoneal macrophages. J Leukoc Biol 1987;42:704-707.
42. Kline JN, Hunninghake GM, He B, et al. Synergistic activation of the human cytomegalovirus major immediate early promotor by prostaglandin E2 and cytokines. Exp Lung Res 1998;24:3-14.